Tokyo, Japan

Yuichi Aizawa

This inventor holds 32 USPTO granted patents, primarily in Golf Club Technology. Top assignees: Daiwa Golf Co., Ltd., Daiwa Seiko, Inc., Sankyo Company, Limited. Active years: 1987-2000.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yuichi Aizawa. Retrieved from https://idiyas.com/inventor/yuichi-aizawa

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 1.7

ph-index = 22

Forward Citations = 1,989(Granted Patents)


Location History:

  • Hiromachi, JP (1989 - 1990)
  • Kodaira, JP (1992)
  • Kurume, JP (1995)
  • Higashikurume, JP (1992 - 1997)
  • Hachioji, JP (1997)
  • Tokyo, JP (1987 - 1999)
  • Yokohama, JP (1999 - 2000)

Company Filing History:


Years Active: 1987-2000

Loading Chart...
Areas of Expertise:
Isoxazole Derivatives
Golf Club Head
Iron Club Set
Hollow Cylindrical Member
Thiazolidine Compounds
Beryllium Face Plate
Striking Face
Thiazole Derivatives
Iron Club Head
Golf Club Set
32 patents (USPTO):Explore Patents

Title: Yuichi Aizawa: A Pioneer in Isoxazole Compounds

Introduction

Yuichi Aizawa, a distinguished inventor based in Tokyo, Japan, has made significant contributions to the field of pharmaceutical chemistry, particularly through his work on isoxazole derivatives. With a robust portfolio of 32 patents, Aizawa has become a notable figure in innovation, focusing on compounds that hold therapeutic potential for various neurological diseases.

Latest Patents

Among his latest innovations are several patents concerning isoxazole derivatives. These compounds are characterized by the following features: R1 can represent hydrogen, halogen, alkyl, alkoxy, hydroxyl, alkylthio, amino, alkanoyl, alkanoylamino, alkanoyloxy, alkoxycarbonyl, carboxy, (alkylthio)thiocarbonyl, carbamoyl, nitro, or cyano. R2 is an amino group, while m can be either 1, 2, or 3, and n ranges from 1 to 6. Ring A is defined as a phenyl or naphthyl ring, and X may be oxygen or sulfur. Aizawa's isoxazole compounds exhibit excellent monoamine oxidase inhibitory activity, proving useful in the treatment of Parkinson's disease, depression, and Alzheimer's disease.

Career Highlights

Aizawa has played pivotal roles in various companies throughout his career, including Daiwa Golf Co., Ltd. and Daiwa Seiko, Inc. His work at these organizations has contributed significantly to the advancement of chemical innovations, particularly in the realm of pharmaceuticals.

Collaborations

Yuichi Aizawa has collaborated with notable colleagues such as Yasuto Imai and Mahito Kimura. These partnerships have allowed for a dynamic exchange of ideas and expertise, further enhancing the quality and impact of Aizawa's inventions.

Conclusion

Yuichi Aizawa's dedication to research and innovation has positioned him as a key contributor to the field of pharmaceutical chemistry. His ongoing work with isoxazole derivatives continues to offer promising solutions for some of the most challenging neurological disorders, highlighting the importance of creative thought and collaboration in advancing medical science.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…